Comparison of Methods to Facilitate Rapid Sequence Intubation
NCT ID: NCT01479751
Last Updated: 2012-08-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
110 participants
INTERVENTIONAL
2011-11-30
2012-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ketamine
Patients receive ketamine 0.5 mg/kg 2 min before Roc injection.
Ketamine
patients receive ketamine 0.5 mg/kg 2 min before Roc injection.
priming
Patients receive Roc 0.06 mg/ kg as a priming dose 3 min before injection of Roc 0.54 mg/kg.
rocuronium
Patients receive Roc 0.06 mg/ kg as a priming dose 3 min before injection of Roc 0.54 mg/kg.
Roc 0.9
Patients receive Roc 0.9 mg/kg as an induction dose.
No interventions assigned to this group
Control
Patients receive Roc 0.6 mg/kg without any pretreatments of Mg, ketamine, or priming.
No interventions assigned to this group
Mg
Patients receive magnesium sulfate (MgSO4) 50 mg/kg over 10 min before Roc injection.
Magnesium Sulfate
Patients receive MgSO4 50 mg/kg for 10 min before injection of Roc 0.6 mg/kg.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Magnesium Sulfate
Patients receive MgSO4 50 mg/kg for 10 min before injection of Roc 0.6 mg/kg.
Ketamine
patients receive ketamine 0.5 mg/kg 2 min before Roc injection.
rocuronium
Patients receive Roc 0.06 mg/ kg as a priming dose 3 min before injection of Roc 0.54 mg/kg.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ASA 1 - 2,
* patients scheduled for elective surgery under general anesthesia,
* BMI 18.5-24.9 kg/m2
* Mallampati class I-II
Exclusion Criteria
* cardiac/hepatic/renal insufficiency,
* pregnant.
* anticipated difficult airway
* medications that influence neuromuscular transmission
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seoul National University Bundang Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kim Mihyun
clinical professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mihyun Kim, doctor
Role: PRINCIPAL_INVESTIGATOR
Seoul National University Bundang Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Seoul National University Bundang hopital
Seongnam-si, Gyeonggi-do, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
facilitating RSI
Identifier Type: -
Identifier Source: org_study_id